Susanna C Larsson1, Agneta Akesson, Alicja Wolk. 1. Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden. susanna.larsson@ki.se
Abstract
BACKGROUND: Acrylamide, a probable human carcinogen, can be formed in carbohydrate-rich foods cooked at high temperatures. Whether dietary acrylamide intake is associated with the risk of cancer in humans is uncertain. We aimed to assess the relation between dietary acrylamide intake and the incidence of epithelial ovarian cancer. METHODS: The Swedish Mammography Cohort is a population-based prospective study of 61,057 Swedish women. Diet was assessed with a food-frequency questionnaire at baseline in 1987-1990 and again in 1997. RESULTS: During a mean follow-up of 17.5 years, we ascertained 368 incident cases of ovarian cancer. We observed no association between acrylamide intake and the risk of ovarian cancer. Compared with the lowest quartile of acrylamide intake (mean intake, 16.9 microg/day), the multivariable rate ratios for the highest quartile (mean intake, 32.5 microg/day) were 0.86 (95% confidence interval, 0.63-1.16) for total ovarian cancer and 1.05 (95% confidence interval, 0.68-1.63) for serous ovarian cancer (n=182 cases). CONCLUSIONS: The results from this prospective study provide no evidence that dietary acrylamide in amounts typically consumed by Swedish women is associated with the risk of ovarian cancer.
BACKGROUND:Acrylamide, a probable human carcinogen, can be formed in carbohydrate-rich foods cooked at high temperatures. Whether dietary acrylamide intake is associated with the risk of cancer in humans is uncertain. We aimed to assess the relation between dietary acrylamide intake and the incidence of epithelial ovarian cancer. METHODS: The Swedish Mammography Cohort is a population-based prospective study of 61,057 Swedish women. Diet was assessed with a food-frequency questionnaire at baseline in 1987-1990 and again in 1997. RESULTS: During a mean follow-up of 17.5 years, we ascertained 368 incident cases of ovarian cancer. We observed no association between acrylamide intake and the risk of ovarian cancer. Compared with the lowest quartile of acrylamide intake (mean intake, 16.9 microg/day), the multivariable rate ratios for the highest quartile (mean intake, 32.5 microg/day) were 0.86 (95% confidence interval, 0.63-1.16) for total ovarian cancer and 1.05 (95% confidence interval, 0.68-1.63) for serous ovarian cancer (n=182 cases). CONCLUSIONS: The results from this prospective study provide no evidence that dietary acrylamide in amounts typically consumed by Swedish women is associated with the risk of ovarian cancer.
Authors: Jing Xie; Kathryn L Terry; Elizabeth M Poole; Kathryn M Wilson; Bernard A Rosner; Walter C Willett; Hubert W Vesper; Shelley S Tworoger Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-02-15 Impact factor: 4.254
Authors: T Hirvonen; J Kontto; M Jestoi; L Valsta; K Peltonen; P Pietinen; S M Virtanen; H Sinkko; C Kronberg-Kippilä; D Albanes; J Virtamo Journal: Cancer Causes Control Date: 2010-09-22 Impact factor: 2.506
Authors: Kathryn M Wilson; Lorelei A Mucci; Bernard A Rosner; Walter C Willett Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-08-06 Impact factor: 4.254
Authors: Janneke G Hogervorst; Renee T Fortner; Lorelei A Mucci; Shelley S Tworoger; A Heather Eliassen; Susan E Hankinson; Kathryn M Wilson Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-27 Impact factor: 4.254
Authors: Mireia Obón-Santacana; Heinz Freisling; Petra H Peeters; Leila Lujan-Barroso; Pietro Ferrari; Marie-Christine Boutron-Ruault; Sylvie Mesrine; Laura Baglietto; Renee Turzanski-Fortner; Verena A Katzke; Heiner Boeing; J Ramón Quirós; Elena Molina-Portillo; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Melissa A Merritt; Marc J Gunter; Antonia Trichopoulou; Pagona Lagiou; Androniki Naska; Domenico Palli; Sabina Sieri; Rosario Tumino; Valentina Fiano; Rocco Galassom; H B As Bueno-de-Mesquita; N Charlotte Onland-Moret; Annika Idahl; Eva Lundin; Elisabete Weiderpass; Hubert Vesper; Elio Riboli; Eric J Duell Journal: Int J Cancer Date: 2015-10-01 Impact factor: 7.396
Authors: Mireia Obón-Santacana; Leila Lujan-Barroso; Ruth C Travis; Heinz Freisling; Pietro Ferrari; Gianluca Severi; Laura Baglietto; Marie-Christine Boutron-Ruault; Renée T Fortner; Jennifer Ose; Heiner Boeing; Virginia Menéndez; Emilio Sánchez-Cantalejo; Saioa Chamosa; José María Huerta Castaño; Eva Ardanaz; Kay-Tee Khaw; Nick Wareham; Melissa A Merritt; Marc J Gunter; Antonia Trichopoulou; Eleni-Maria Papatesta; Eleni Klinaki; Calogero Saieva; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H B Bueno-de-Mesquita; Petra H Peeters; N Charlotte Onland-Moret; Annika Idahl; Eva Lundin; Elisabete Weiderpass; Hubert W Vesper; Elio Riboli; Eric J Duell Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-11-23 Impact factor: 4.254
Authors: Mireia Obón-Santacana; Petra H M Peeters; Heinz Freisling; Laure Dossus; Françoise Clavel-Chapelon; Laura Baglietto; Helena Schock; Renée T Fortner; Heiner Boeing; Anne Tjønneland; Anja Olsen; Kim Overvad; Virginia Menéndez; Maria-José Sanchez; Nerea Larrañaga; José María Huerta Castaño; Aurelio Barricarte; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Melissa A Merritt; Antonia Trichopoulou; Dimitrios Trichopoulos; Philippos Orfanos; Giovanna Masala; Sabina Sieri; Rosario Tumino; Paolo Vineis; Amalia Mattiello; H B Bueno-de-Mesquita; N Charlotte Onland-Moret; Elisabeth Wirfält; Tanja Stocks; Annika Idahl; Eva Lundin; Guri Skeie; Inger T Gram; Elisabete Weiderpass; Elio Riboli; Eric J Duell Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-10-09 Impact factor: 4.254